0001140361-23-025560.txt : 20230518
0001140361-23-025560.hdr.sgml : 20230518
20230518201723
ACCESSION NUMBER: 0001140361-23-025560
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murugan Amar
CENTRAL INDEX KEY: 0001809916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 23937707
MAIL ADDRESS:
STREET 1: C/O ATARA BIOTHERAPEUTICS, INC.
STREET 2: 611 GATEWAY BOULEVARD,SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2380 CONEJO SPECTRUM ST
STREET 2: SUITE 200
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: 805-623-4244
MAIL ADDRESS:
STREET 1: 2380 CONEJO SPECTRUM ST
STREET 2: SUITE 200
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
4
1
form4.xml
X0407
4
2023-05-16
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001809916
Murugan Amar
C/O ATARA BIOTHERAPEUTICS, INC.
2380 CONEJO SPECTRUM ST, SUITE 200
THOUSAND OAKS
CA
91320
true
EVP, Chief Legal Officer
false
Common Stock
2023-05-16
4
S
0
7404
2.037
D
271930
D
Common Stock
2023-05-16
4
S
0
985
2.038
D
270945
D
Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 and May 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
/s/ Jeff Kiekhofer, Attorney-in-Fact for Amar Murugan
2023-05-18